Related content

Dispute settlement understanding on the use of BOTOX^® in chronic migraine

By Martelletti Paolo  

The Journal of Headache and Pain, Vol. 12, Iss. 1, 2011-02 ,pp. : 1-2

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of a New Formulation of Sumatriptan Tablets when Administered Early in a Migraine Attack

By Carpay Hans   Cruccu Giorgio   Boswell Diane   Kinrade Frances   Jones Martin  

Headache Care, Vol. 1, Iss. 1, 2004-03 ,pp. : 60-62

Informa Healthcare

Access to resources Recommend Favorite

Ability to Function Following Treatment with a New Formulation of Sumatriptan Tablets

By Cruccu Giorgio   Carpay Hans   Kwong Jackie   Boswell Diane   Alderton Claire  

Headache Care, Vol. 1, Iss. 1, 2004-03 ,pp. : 63-65

Informa Healthcare

Access to resources Recommend Favorite

IPX066: a new intermediate- and extended-release carbidopa-levodopa formulation

By Yacoubian Talene A  

Neurodegenerative Disease Management, Vol. 3, Iss. 2, 2013-04 ,pp. : 123-131

Future Medicine

Access to resources Recommend Favorite

Experience with onabotulinumtoxinA (BOTOX) in chronic refractory migraine: focus on severe attacks

By Oterino A.   Ramón C.   Pascual J.  

The Journal of Headache and Pain, Vol. 12, Iss. 2, 2011-04 ,pp. : 235-238

Springer Publishing Company

Access to resources Recommend Favorite